|
|
|
27.03.26 - 08:24
|
Notice of Investor AB′s Annual General Meeting on May 7, 2026 (Cision)
|
|
|
Investor AB (publ) summons to the Annual General Meeting (the “Meeting”) to be held on Thursday, May 7, 2026, at 4:00 p.m. at China Teatern, Berzelii Park 9, Stockholm, Sweden. Registration for the Meeting will commence at 2:30 p.m. The “Investor Dialog” begins at 3:00 p.m. – a dialogue between Investor's Chair of the Board, Jacob Wallenberg, Investor's President, Christian Cederholm, and our shareholders. The shareholders will also have the opportunity to exercise their voting rights by voting in advance prior to the Meeting.
The Meeting and the Investor Dialog can be followed online in...
|
|
|
27.03.26 - 08:18
|
The Nomination Committee′s proposal for election of members of the Board of Directors of Investor AB (Cision)
|
|
|
The Nomination Committee of Investor AB submits the following proposals for resolution at the Annual General Meeting on May 7, 2026, with regard to the number and election of members of the Board of Directors.
The Nomination Committee proposes eleven members of the Board of Directors and no deputy members of the Board of Directors.
The Nomination Committee proposes the following persons for re-election as members of the Board of Directors: Katarina Berg, Christian Cederholm, Magdalena Gerger, Sven Nyman, Mats Rahmström, Grace Reksten Skaugen, Hans Stråberg, Fred Wallenberg, Jacob...
|
|
|
|
|
22.01.26 - 11:24
|
Investor AB Full Year Income Climbs (AFX)
|
|
|
STOCKHOLM (dpa-AFX) - Investor AB (IVSBF) announced a profit for its full year that Increased, from last yearThe company's bottom line totaled SEK157.340 billion, or SEK51.39 per share. This compa......
|
|
|
|
|
20.01.26 - 10:36
|
Affibody Carries Out Fully Guaranteed Rights Issue of SEK 307 Million (Cision)
|
|
|
Stockholm, Sweden, January 20, 2026. Affibody Medical AB (publ) (“Affibody”) today announced that the Board of Directors, with authorization from the annual general meeting on May 27, 2025, has resolved to carry out a fully guaranteed rights issue of SEK 307 million.
Affibody's main shareholder Patricia Industries, part of Investor AB, has via its subsidiary Duba AB committed to subscribe for its pro rata share, as well as any remaining shares not subscribed for by other shareholders. The full amount of the rights issue is thus guaranteed. Payment for the new shares is expected to comprise...
|
|
|
28.11.25 - 12:54
|
Ad-hoc News: CGRE AG (EQS)
|
|
|
CGRE AG: CGRE AG schließt Grundsatzvereinbarung mit strategischem Investor ab und beschließt Barkapitalerhöhung unter Ausnutzung des genehmigten Kapitals mit Bezugsrechtsausschluss...
|
|
|
20.11.25 - 07:36
|
Trevian and Sagax secure the future use of Nokia′s Oulu facilities – asset management agreement signed (Cision)
|
|
|
Swedish-listed property investor AB Sagax and Trevian Asset Management have entered into an agreement to manage and redevelop Nokia's outgoing facilities in Oulu, one of the company's largest sites globally alongside its Espoo headquarters. As Nokia relocates to new premises during 2025, Trevian and Sagax will work together to reposition the extensive campus – close to 70,000 square metres with significant remaining development rights – for its next long-term use.
Trevian has conducted a comprehensive feasibility study examining commercial pathways for the site, including potential occupier...
|
|
|
|
|
21.10.25 - 08:36
|
Epiroc ABs Nomination Committee for the Annual General Meeting 2026 (Cision)
|
|
|
Stockholm, Sweden: According to the Instruction for the Nomination Committee adopted by the Annual General Meeting of Epiroc AB, the Nomination Committee should consist of representatives for the four shareholders, directly registered or ownership grouped, controlling the largest number of votes in Epiroc AB that desire to appoint a member. In addition thereto, the Chair of the Board of Directors shall be a member.
The following persons will form the Nomination Committee for the Annual General Meeting 2026.
Petra Hedengran - Investor AB (Chair)
Caroline Sjösten - Swedbank Robur Fonder AB...
|
|
|
|
|
|
|
19.09.25 - 07:30
|
Husqvarna AB′s Nomination Committee for the 2026 Annual General Meeting (Cision)
|
|
|
The members of the Nomination Committee for the Husqvarna AB 2026 Annual General Meeting (“AGM”) have now been appointed, as follows:
Petra Hedengran (Chair, appointed by Investor AB)
Louise Lindh (appointed by L E Lundbergföretagen AB)
Fredrik Ahlin (appointed by If Skadeförsäkring AB)
Oskar Börjesson (appointed by Livförsäkringsbolaget Skandia)
Torbjörn Lööf (Board Chair of Husqvarna AB)
Such appointments have been made in accordance with the rules last approved by the Husqvarna AB AGM. Those rules state that the Nomination Committee shall consist of one representative...
|
|
|
16.09.25 - 08:36
|
Nomination Committee for the Annual General Meeting 2026 (Cision)
|
|
|
Nacka, Sweden, September 16, 2025: The following representatives of Atlas Copco AB's shareholders, together with the Chair of the Board, Hans Stråberg, will form the nomination committee for the Annual General Meeting 2026.
Representatives:
Petra Hedengran, Investor AB (Chair of the Nomination Committee)
Joachim Spetz, Swedbank Robur Fonder AB
Helen Fasth Gillstedt, Handelsbanken Fonder AB
Filippa Gerstädt, Nordea Funds AB
The Annual General Meeting of Atlas Copco AB will be held on April 28, 2026.
Shareholders who wish to submit proposals to the nomination committee can do...
|
|
|
12.09.25 - 08:18
|
Investor AB′s Nomination Committee for the 2026 Annual General Meeting (Cision)
|
|
|
Investor AB's Nomination Committee for the Annual General Meeting 2026 has been appointed based on the ownership structure as of August 29, 2025.
The Nomination Committee consists of:
Leif Johansson, Wallenberg Foundations
Katarina Romberg, AMF Tjänstepension och AMF Fonder
Magnus Carlsson, SEB Foundation
Peder Hasslev, Alecta
Jacob Wallenberg, Chair of the Board of Investor AB
Shareholders having appointed members to the Nomination Committee represent approximately 65 percent of the voting rights for all shares of Investor AB.
The Annual General Meeting of Investor AB will be...
|
|
|
|
|
|
|
|
|
|
|
24.06.25 - 02:48
|
ArrePath Announces Closing of Their Next Financing Round and Appointment of a New Board Chair (Business Wire)
|
|
|
PRINCETON, N.J.--(BUSINESS WIRE)--ArrePath, a company applying its proprietary artificial intelligence and machine learning platform together with deep R&D technical expertise to address the challenge of best-in-class antibacterial drug discovery, announced several business updates. First, the company has raised the next round of financing to advance its pipeline and continue to expand the scope and capabilities of its discovery platform. The Boehringer Ingelheim Venture Fund led the financing, which also included existing investors Insight Partners, Innospark, and Nor'easter Ventures, and new investor AB Magnitude.
“We are grateful for the ongoing support of our strong investor base and welcome our new investor, AB Magnitude, to ArrePath,” said Kevin Krause, President and CEO. “This raise, in combination with our recently announced non-dilutive funding awards from PACE and CARB-X, enables ArrePath to advance our lead program, AP-001, towards development candidate nomination and eventual Phase 1 st...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
